Neil A Bhowmick
Overview
Explore the profile of Neil A Bhowmick including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
103
Citations
4937
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang L, Teng P, Cavassani K, Wang J, Grasso C, Watson J, et al.
Clin Cancer Res
. 2025 Mar;
PMID: 40063516
Background: Circulating tumor cells (CTCs) with a very-small-nuclear phenotype (vsnCTCs) in prostate cancer (PCa) are characterized by nuclei smaller than 8.5 μm. Our previous studies established an association between vsnCTCs...
2.
Yang Y, Kim J, Wang Z, Kim J, Kim S, Cho G, et al.
J Clin Invest
. 2025 Feb;
PMID: 39946200
Steatotic liver enhances liver metastasis of colorectal cancer, but this process is not fully understood. Steatotic liver induced by a high-fat diet (HFD) increases cancer-associated fibroblast (CAF) infiltration and collagen...
3.
Makwana K, Velazquez E, Marzese D, Smith B, Bhowmick N, Faries M, et al.
Front Immunol
. 2025 Jan;
15:1495032.
PMID: 39742254
Transmembrane integrin-associated protein functions as a potent innate immunity checkpoint and is upregulated by many types of malignant cells, including melanoma during tumor progression. Binding of to its target receptor,...
4.
Rohena-Rivera K, You S, Kim M, Billet S, Hoeve J, Gonzales G, et al.
JCI Insight
. 2024 Nov;
9(24).
PMID: 39509334
Chemotherapy is often combined with surgery for muscle invasive and nonmuscle invasive bladder cancer (BCa). However, 70% of the patients recur within 5 years. Metabolic reprogramming is an emerging hallmark...
5.
Muranaka H, Akinsola R, Billet S, Pandol S, Hendifar A, Bhowmick N, et al.
Cancers (Basel)
. 2024 Mar;
16(5).
PMID: 38473414
Glutamine, a multifaceted nonessential/conditionally essential amino acid integral to cellular metabolism and immune function, holds pivotal importance in the landscape of cancer therapy. This review delves into the intricate dynamics...
6.
Ziman B, Yang Q, Zheng Y, Sheth M, Nam C, Zhao H, et al.
Cell Death Dis
. 2024 Feb;
15(2):152.
PMID: 38373993
Unlike most cancer types, the incidence of esophageal adenocarcinoma (EAC) has rapidly escalated in the western world over recent decades. Using whole genome bisulfite sequencing (WGBS), we identify the transcription...
7.
Zhang L, Zheng Y, Chien W, Ziman B, Billet S, Koeffler H, et al.
Cancers (Basel)
. 2023 Nov;
15(22).
PMID: 38001638
ARID1A, a member of the chromatin remodeling SWI/SNF complex, is frequently lost in many cancer types, including esophageal adenocarcinoma (EAC). Here, we study the impact of ARID1A deficiency on the...
8.
Muranaka H, Hendifar A, Osipov A, Moshayedi N, Placencio-Hickok V, Tatonetti N, et al.
Cancers (Basel)
. 2023 Jun;
15(11).
PMID: 37296982
Pancreatic cancer (PC) is one of the deadliest cancers. Developing biomarkers for chemotherapeutic response prediction is crucial for improving the dismal prognosis of advanced-PC patients (pts). To evaluate the potential...
9.
Thiruvalluvan M, Bhowmick N
Cancers (Basel)
. 2023 Jun;
15(11).
PMID: 37296976
Tumorigenesis is a result of cell-intrinsic epigenomic and genomic changes as well as cell-extrinsic factors [...].
10.
Borah S, Mishra R, Dey S, Suchanti S, Bhowmick N, Giri B, et al.
Mitochondrion
. 2023 Jun;
71:63.
PMID: 37276794
No abstract available.